Your browser doesn't support javascript.
loading
Corrigendum: Revealing the mechanism of Huazhi Rougan granule in the treatment of nonalcoholic fatty liver through intestinal flora based on 16S rRNA, metagenomic sequencing and network pharmacology.
Liu, Yingying; Tan, Yingying; Huang, Jiaqi; Wu, Chao; Fan, Xiaotian; Stalin, Antony; Lu, Shan; Wang, Haojia; Zhang, Jingyuan; Zhang, Fanqin; Wu, Zhishan; Li, Bing; Huang, Zhihong; Chen, Meilin; Cheng, Guoliang; Mou, Yanfang; Wu, Jiarui.
Afiliação
  • Liu Y; Department of Clinical Chinese Pharmacy, School of Chinese Materia Medica, Beijing University of Chinese Medicine, Beijing, China.
  • Tan Y; Department of Clinical Chinese Pharmacy, School of Chinese Materia Medica, Beijing University of Chinese Medicine, Beijing, China.
  • Huang J; Department of Clinical Chinese Pharmacy, School of Chinese Materia Medica, Beijing University of Chinese Medicine, Beijing, China.
  • Wu C; Department of Clinical Chinese Pharmacy, School of Chinese Materia Medica, Beijing University of Chinese Medicine, Beijing, China.
  • Fan X; Department of Clinical Chinese Pharmacy, School of Chinese Materia Medica, Beijing University of Chinese Medicine, Beijing, China.
  • Stalin A; Institute of Fundamental and Frontier Sciences, University of Electronic Science and Technology of China, Chengdu, China.
  • Lu S; Department of Clinical Chinese Pharmacy, School of Chinese Materia Medica, Beijing University of Chinese Medicine, Beijing, China.
  • Wang H; Department of Clinical Chinese Pharmacy, School of Chinese Materia Medica, Beijing University of Chinese Medicine, Beijing, China.
  • Zhang J; Department of Clinical Chinese Pharmacy, School of Chinese Materia Medica, Beijing University of Chinese Medicine, Beijing, China.
  • Zhang F; Department of Clinical Chinese Pharmacy, School of Chinese Materia Medica, Beijing University of Chinese Medicine, Beijing, China.
  • Wu Z; Department of Clinical Chinese Pharmacy, School of Chinese Materia Medica, Beijing University of Chinese Medicine, Beijing, China.
  • Li B; State Key Laboratory of Generic Manufacture Technology of Chinese Traditional Medicine, Linyi, China.
  • Huang Z; Department of Clinical Chinese Pharmacy, School of Chinese Materia Medica, Beijing University of Chinese Medicine, Beijing, China.
  • Chen M; Department of Clinical Chinese Pharmacy, School of Chinese Materia Medica, Beijing University of Chinese Medicine, Beijing, China.
  • Cheng G; State Key Laboratory of Generic Manufacture Technology of Chinese Traditional Medicine, Linyi, China.
  • Mou Y; State Key Laboratory of Generic Manufacture Technology of Chinese Traditional Medicine, Linyi, China.
  • Wu J; Department of Clinical Chinese Pharmacy, School of Chinese Materia Medica, Beijing University of Chinese Medicine, Beijing, China.
Front Pharmacol ; 14: 1243304, 2023.
Article em En | MEDLINE | ID: mdl-37564177
ABSTRACT
[This corrects the article DOI 10.3389/fphar.2022.875700.].
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2023 Tipo de documento: Article